# US 2003/0228648 A1 · Mammalian catalase-dependent oxidation processes and methods for stimulating oxidative activities

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0228648 A1
- Document ID: US20030228648A1
- Status: Published application
- Kind: A1
- Application number: 10/165,841
- Filed: 2002-06-07
- Published: 2003-12-11
- Earliest claimed: 2002-06-07
- Assignees: University of Medicine and Dentistry of New Jersey
- Inventors: Jeffrey D. Laskin; Anna Marie Vetrano; Diane Heck
- Web page: https://patentgrep.com/patent/US20030228648A1

## CPC

- C12N 9/0065: {acting on hydrogen peroxide as acceptor (1.11)}
- C12Q 1/30: involving catalase
- C12Y 111/01006: Catalase (1.11.1.6)
- G01N 2500/02: Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A catalase-dependent enzymatic oxidation process wherein a substrate to be oxidized is contacted with catalase in the absence of hydrogen peroxide is provided. Also provided are methods for using this process in a variety of biomedical, clinical and diagnostic applications as well as industrial processes. A method for stimulating the enzymatic oxidation process by treatment with ultraviolet light and uses for this method are also provided.

## Claims

### Claim 1

An enzymatic oxidation process wherein a selected substrate to be oxidized is contacted with mammalian catalase in the absence of hydrogen peroxide.

### Claim 2 (depends on 1)

The enzymatic oxidation process of claim 1 wherein the selected substrate is oxidized by mammalian catalase to a fluorescent product.

### Claim 3 (depends on 2)

The enzymatic oxidation process of claim 2 used in chemifluorescence techniques.

### Claim 4 (depends on 1)

The enzymatic oxidation process of claim 1 wherein the selected substrate is oxidized by mammalian catalase to a chemiluminescent product.

### Claim 5 (depends on 4)

The enzymatic oxidation process of claim 4 used in chemiluminescence techniques.

### Claim 6 (depends on 1)

The enzymatic oxidation process of claim 1 used in bleaching or anti dye-transfer techniques.

### Claim 7 (depends on 1)

The enzymatic oxidation process of claim 1 used to polymerize lignin.

### Claim 8 (depends on 1)

The enzymatic oxidation process of claim 1 used to polymerize phenolic substances.

### Claim 9 (depends on 1)

The enzymatic oxidation process of claim 1 used in an antimicrobial treatment of microorganisms or viruses.

### Claim 10 (depends on 1)

The enzymatic oxidation process of claim 1 used to detoxify phenolic pollutants.

### Claim 11

A chemifluorescence detection technique comprising a mammalian catalase enzyme and a selected substrate oxidized by the mammalian catalase enzyme to a fluorescent product.

### Claim 12

A chemiluminescent detection technique comprising a mammalian catalase enzyme and a selected substrate oxidized by the mammalian catalase enzyme to a chemiluminescent product.

### Claim 13

A screening assay for compounds that inhibit mammalian catalase comprising measuring oxidation of a selected substrate by mammalian catalase in the presence and absence of a test compound, wherein a decrease in oxidation of the selected substrate in the presence of the test compound is indicative of the test compound inhibiting mammalian catalase activity.

### Claim 14 (depends on 13)

The assay of claim 13 wherein the test compound identified as an inhibitor of mammalian catalase activity is useful as a chemopreventative agent.

### Claim 15 (depends on 13)

The assay of claim 13 wherein the test compound identified as an inhibitor of mammalian catalase activity prevents breakdown of drugs by oxidation reaction.

### Claim 16

A screening assay to identify pharmacological agents activated by oxidation comprising contacting the pharmacological agent with mammalian catalase and measuring for activation of the pharmacological agent.

### Claim 17 (depends on 16)

The screening assay of claim 16 wherein the pharmacological agent is a prodrug and activation is measured by amount of drug produced.

### Claim 18

A method for accelerating oxidation of a selected substrate by mammalian catalase comprising exposing a mixture containing the selected substrate and mammalian catalase to ultraviolet light.

### Claim 19

A method for identifying compounds which inhibit damage of tissue by exposure to ultraviolet light comprising measuring oxidation of a mixture of a selected substrate and mammalian catalase, said mixture being exposed to ultraviolet light, in the presence and absence of a test compound, wherein a decrease in oxidation of the substrate in the presence of the test compound is indicative of the test compound inhibiting damage of tissue exposed to ultraviolet light.
